Assignee
PALESE PETER
US·8 granted patents·4 pending applications·108 citations·filing 2005–2011
Top patents by PatentIndex Score
12 records- 0196US8591881B2Chimeric Newcastle disease viruses and uses thereofPALESE PETER·Filed 2010·Granted Nov 26, 2013·52 cites·16 claims
- 0292US8057803B2Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsPALESE PETER·Filed 2008·Granted Nov 15, 2011·12 cites·43 claims
- 0391US8124101B2Genetically engineered swine influenza virus and uses thereofPALESE PETER·Filed 2005·Granted Feb 28, 2012·15 cites·6 claims
- 0490US8137676B2Genetically engineered equine influenza virus and uses thereofPALESE PETER·Filed 2005·Granted Mar 20, 2012·13 cites·6 claims
- 0588US9387242B2Chimeric viruses presenting non-native surface proteins and uses thereofPALESE PETER·Filed 2006·Granted Jul 12, 2016·7 cites·43 claims
- 0686US8999352B2Genetically engineered swine influenza virus and uses thereofPALESE PETER·Filed 2011·Granted Apr 7, 2015·7 cites·36 claims
- 0780US8765139B2Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsPALESE PETER·Filed 2011·Granted Jul 1, 2014·2 cites·28 claims
- 0872US2009061521A1Recombinant negative strand RNA virus expression systems and vaccinesPALESE PETER·Filed 2008·Application pending·0 cites
- 0969US9352033B2Methods for the propagation of modified influenza viruses in embryonated eggsPALESE PETER·Filed 2009·Granted May 31, 2016·0 cites·25 claims
- 1069US2010158942A1Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsPALESE PETER·Filed 2009·Application pending·0 cites
- 1162US2012058538A1Helper-free Rescue of Recombinant Negative Strand RNA Virus SystemsPALESE PETER·Filed 2011·Application pending·0 cites
- 1252US2006019350A1Recombinant negative strand RNA virus expression system and vacccinesPALESE PETER·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →